PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Aurora Biomed, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Aurora Biomed, Inc. Launches New Line of Water Purification Systems - Aurora's Crysta Series - Pure water for better science - AuroraBiomed.com
Aurora Biomed, Inc. Launches New Line of Water Purification Systems

 

NewswireToday - /newswire/ - Vancouver, British Columbia, Canada, 2009/02/25 - Aurora's Crysta Series - Pure water for better science - AuroraBiomed.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Aurora Biomed, Inc., a leading developer of solutions for life science, analytical and drug discovery research, is adding a new series of laboratory water purification systems to complement its existing line of high precision instruments. The Crysta Series is a high quality water purification system that will produce better technical results for even the most demanding scientific applications.

The Crysta 500, 1000, and 2000 systems serve three different areas of scientific applications. These applications range from general pure water use in buffer preparation and high purity glassware rinsing to critical use in high performance liquid chromatography and polymerase chain reactions. Aurora’s Crysta Series produces highly purified lab water that meets ASTM and CLSI clinical laboratory standards. All three models use unique networks of filtration systems developed to produce the highest quality Type 1 and Type 2 pure water. The Crysta 500 uses a 6 step filtration system to purify tap water into reverse osmosis water and then into even purer Type 2 deionized water. The Crysta 1000 system produces Type 1 ultrapure analytical water using Ultrapure Polishing Cartridges. The Crysta 2000 system uses advanced 5000 Doulton Ultrafilters and Double Wavelength Ultraviolet Lamps to produce the purest Type 1 water for use in critical PCR and HPLC applications.

The Crysta Series uses unique filtration networks to consistently deliver high quality pure lab water for better technical results. With special features such as walk-away unattended operation, real time display of purity levels, and innovative cartridge monitoring systems, the Crysta Series is a dependable, high quality and high performance laboratory water purification system that will meet and surpass the demands of any pure water needs.

About Aurora

Aurora Biomed, Inc. (aurorabiomed.com) provides enabling technologies for drug discovery research, analytical chemistry and laboratory automation. Aurora develops the VERSA™ liquid-handling workstations for greater efficiency and higher data quality in PCR and Nucleic Acid Prep, as well as the Atomic Absorption Spectrometers and Microwave Digestion Systems. Aurora Biomed hosts the annual Ion Channel Retreat for scientific discourse on ion channel disciplines and is headquartered in Vancouver, BC, Canada, with global sales, support and service offices.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Aurora Biomed, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Aurora Biomed, Inc. Launches New Line of Water Purification Systems

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Clarence Chew - AuroraBiomed.com 
1-800-883-2918 info[.]aurorabiomed.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Aurora Biomed, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Aurora Biomed, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  1Click Games





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)